Literature DB >> 24108111

Gene expression profiles of ileal inflammatory bowel disease correlate with disease phenotype and advance understanding of its immunopathogenesis.

Shay Ben-Shachar1, Henit Yanai, Liran Baram, Hofit Elad, Elhanan Meirovithz, Amos Ofer, Eli Brazowski, Hagit Tulchinsky, Metsada Pasmanik-Chor, Iris Dotan.   

Abstract

BACKGROUND: Pouchitis may develop in patients with ulcerative colitis undergoing pouch surgery. We aimed to evaluate the de novo inflammation developing in the ileal pouch, hypothesizing that it may be similar to ileitis in Crohn's disease (CD).
METHODS: Patients with ulcerative colitis pouch were prospectively recruited, stratified according to disease behavior into normal pouch, chronic pouchitis, and Crohn's-like disease of the pouch groups, and compared with controls. Gene expression analysis was performed using microarrays, validated by real-time polymerase chain reaction. Gene ontology and clustering were evaluated using bioinformatic tools.
RESULTS: Sixty-six subjects were recruited. Although in ulcerative colitis ileum there were no significant gene expression alterations, patients with normal pouch had 168 significant alterations (fold change ≥ 2, corrected P ≤ 0.05). In chronic pouchitis and Crohn's-like disease of the pouch, 490 and 1152 alterations were detected, respectively. High degree of overlap in gene expression alterations between the pouch subgroups was demonstrated. The magnitude of change correlated with pouch disease behavior. Gene expression profiles were more reflective of disease behavior compared with inflammatory indices. CD ileitis had 358 alterations, with a 90% overlap with pouchitis. Gene ontology analyses revealed multiple biological processes associated with pouch inflammation, including response to chemical stimulus, small molecule metabolic and immune system processes, and specific infection-related pathways such as Staphylococcus aureus, leishmaniasis, and tuberculosis.
CONCLUSIONS: Gene alterations in pouch inflammation and CD overlap, suggesting that inflammatory bowel diseases is a spectrum, rather than distinct diseases. Pouchitis may serve as a model of CD. The novel pathways associated with inflammatory bowel diseases may decipher pathophysiology and suggest targets for intervention.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24108111     DOI: 10.1097/01.MIB.0000437045.26036.00

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  14 in total

1.  Local enema treatment to inhibit FOLH1/GCPII as a novel therapy for inflammatory bowel disease.

Authors:  Abhijit A Date; Rana Rais; Taarika Babu; Jairo Ortiz; Pranjali Kanvinde; Ajit G Thomas; Sarah C Zimmermann; Alexandra J Gadiano; Gilad Halpert; Barbara S Slusher; Laura M Ensign
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

2.  Simulation and visualization of multiple KEGG pathways using BioNSi.

Authors:  Adva Yeheskel; Adam Reiter; Metsada Pasmanik-Chor; Amir Rubinstein
Journal:  F1000Res       Date:  2017-12-11

Review 3.  Looking for Drugs in All the Wrong Places: Use of GCPII Inhibitors Outside the Brain.

Authors:  James J Vornov; Diane Peters; Mike Nedelcovych; Kristen Hollinger; Rana Rais; Barbara S Slusher
Journal:  Neurochem Res       Date:  2019-11-20       Impact factor: 3.996

4.  FOLH1/GCPII is elevated in IBD patients, and its inhibition ameliorates murine IBD abnormalities.

Authors:  Rana Rais; Weiwei Jiang; Huihong Zhai; Krystyna M Wozniak; Marigo Stathis; Kristen R Hollinger; Ajit G Thomas; Camilo Rojas; James J Vornov; Michael Marohn; Xuhang Li; Barbara S Slusher
Journal:  JCI Insight       Date:  2016-08-04

5.  Adherence to the Mediterranean diet is associated with decreased fecal calprotectin in patients with ulcerative colitis after pouch surgery.

Authors:  L Godny; L Reshef; T Pfeffer-Gik; I Goren; H Yanai; H Tulchinsky; U Gophna; I Dotan
Journal:  Eur J Nutr       Date:  2019-12-07       Impact factor: 5.614

6.  Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis.

Authors:  Yong Huang; Sushila Dalal; Dionysios Antonopoulos; Nathaniel Hubert; Laura H Raffals; Kyle Dolan; Christopher Weber; Jeannette S Messer; Bana Jabri; Albert Bendelac; A Murat Eren; David T Rubin; Mitch Sogin; Eugene B Chang
Journal:  Inflamm Bowel Dis       Date:  2017-03       Impact factor: 5.325

Review 7.  Pouchitis: insight into the pathogenesis and clinical aspects.

Authors:  Leandro Minatel Vidal de Negreiros; Lívia Bitencourt Pascoal; Lívia Moreira Genaro; Julian Furtado Silva; Bruno Lima Rodrigues; Michel Gardere Camargo; Carlos Augusto Real Martinez; Cláudio Saddy Rodrigues Coy; Maria de Lourdes Setsuko Ayrizono; João José Fagundes; Raquel Franco Leal
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

8.  Association of angiotensin-converting enzyme gene polymorphisms with Crohn's disease in a Chinese Han population.

Authors:  Jie Zhou; Sichang Zheng; Zhengting Wang; Rong Fan; Jielu Yuan; Jie Zhong
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

9.  Multi-factor mediated functional modules identify novel classification of ulcerative colitis and functional gene panel.

Authors:  Lijie Lai; Hanyang Li; Qi Feng; Jun Shen; Zhihua Ran
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

10.  Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease.

Authors:  Xochitl C Morgan; Boyko Kabakchiev; Levi Waldron; Andrea D Tyler; Timothy L Tickle; Raquel Milgrom; Joanne M Stempak; Dirk Gevers; Ramnik J Xavier; Mark S Silverberg; Curtis Huttenhower
Journal:  Genome Biol       Date:  2015-04-08       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.